The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

BioCompute and WHISE-Embleema Launch Framework for FDA Drug Submissions
Pharma & Human Health

BioCompute and WHISE-Embleema Launch Framework for FDA Drug Submissions

MAY 15, 2019
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
Finance

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

MAY 13, 2019
Synthetic Biologics First Quarter 2019 Operational Highlights and Financial Results
Finance

Synthetic Biologics First Quarter 2019 Operational Highlights and Financial Results

MAY 10, 2019
Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall
Editor's Choice

Modulating the Preterm Gut Microbiota: An Interview with Dr Lindsay Hall

MAY 9, 2019
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
Finance

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

MAY 9, 2019
Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products
Editor's Choice

Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products

MAY 6, 2019
Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress
Finance

Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress

MAY 5, 2019
5-minute Microbiome Science Roundup: April 2019
Editor's Choice

5-minute Microbiome Science Roundup: April 2019

MAY 4, 2019
4D Pharma Clinical Update on MRx0518 Oncology Programmes
Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes

MAY 1, 2019
Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder
Gut-Brain Axis

Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder

MAY 1, 2019
A Bright Outlook for Bacteriophage Applications
Editor's Choice

A Bright Outlook for Bacteriophage Applications

APR 29, 2019